Cargando…

Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1

Diabetic kidney disease is a major cause of chronic kidney condition and the most common complication of diabetes. The cellular senescence participates in the process of diabetic kidney disease, but the specific mechanism is not yet clear. Cell cycle-related protein E2F transcription factor 1 (E2F1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Dan, Li, Zhiyang, Feng, Zhaowei, Yuan, Zhiping, Dai, Yunli, Wu, Xin, Zhang, Fan, Wang, Yuanyuan, Zhou, Yuxia, Liu, Lingling, Shi, Mingjun, Xiao, Ying, Guo, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262145/
https://www.ncbi.nlm.nih.gov/pubmed/35814218
http://dx.doi.org/10.3389/fphar.2022.926211
_version_ 1784742427525906432
author Liang, Dan
Li, Zhiyang
Feng, Zhaowei
Yuan, Zhiping
Dai, Yunli
Wu, Xin
Zhang, Fan
Wang, Yuanyuan
Zhou, Yuxia
Liu, Lingling
Shi, Mingjun
Xiao, Ying
Guo, Bing
author_facet Liang, Dan
Li, Zhiyang
Feng, Zhaowei
Yuan, Zhiping
Dai, Yunli
Wu, Xin
Zhang, Fan
Wang, Yuanyuan
Zhou, Yuxia
Liu, Lingling
Shi, Mingjun
Xiao, Ying
Guo, Bing
author_sort Liang, Dan
collection PubMed
description Diabetic kidney disease is a major cause of chronic kidney condition and the most common complication of diabetes. The cellular senescence participates in the process of diabetic kidney disease, but the specific mechanism is not yet clear. Cell cycle-related protein E2F transcription factor 1 (E2F1) is a member of the E2F transcription factor family, it plays a key role in cellular damage under HG conditions. In this study, we explored whether metformin improves a high-glucose-induced senescence and fibrosis of renal tubular epithelial cells through cell cycle-related protein E2F1. In the in vivo experiments, the recombinant adeno-associated virus (AAV-shE2F1) knockdown E2F1 gene was injected into the tail vein of 16-weeks-old db/db mice for 8 weeks. The 16-week-old db/db mice were administered metformin (260 mg/kg/d) continuously for 8 weeks. The normal control group (NC) and diabetic model group (DM) were set up simultaneously. Mice renal tubular epithelial cells (mRTECs) were cultured in vitro. The cells were randomly divided into the following groups: normal glucose (NG, containing 5.5 mmol/L glucose), high glucose group (HG, containing 30 mmol/L glucose), NG/HG metformin intervention group (NG/HG + Met), NG/HG negative control siRNA transfection group (NG/HG + Control), NG/HG E2F1 siRNA transfection group (NG/HG + siRNA E2F1), HG metformin intervention and overexpression E2F1 plasmid transfection group (HG + Met + overexpress-E2F1). The expression of related indexes were detected by Western blot, real-time polymerase chain reaction (PCR), immunohistochemistry, and immunofluorescence. The results showed that E2F1 knockdown or metformin reduces the degree of renal fibrosis, DNA damage, and cellular senescence in the DM group; metformin also reduced the expression of E2F1. If E2F1 was overexpressed, the effects of metformin in delaying fibrosis and reducing DNA damage and cellular senescence could be weakened. Thus, metformin alleviates high-glucose-induced senescence and fibrosis of renal tubular epithelial cells by downregulating the expression of E2F1.
format Online
Article
Text
id pubmed-9262145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92621452022-07-08 Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1 Liang, Dan Li, Zhiyang Feng, Zhaowei Yuan, Zhiping Dai, Yunli Wu, Xin Zhang, Fan Wang, Yuanyuan Zhou, Yuxia Liu, Lingling Shi, Mingjun Xiao, Ying Guo, Bing Front Pharmacol Pharmacology Diabetic kidney disease is a major cause of chronic kidney condition and the most common complication of diabetes. The cellular senescence participates in the process of diabetic kidney disease, but the specific mechanism is not yet clear. Cell cycle-related protein E2F transcription factor 1 (E2F1) is a member of the E2F transcription factor family, it plays a key role in cellular damage under HG conditions. In this study, we explored whether metformin improves a high-glucose-induced senescence and fibrosis of renal tubular epithelial cells through cell cycle-related protein E2F1. In the in vivo experiments, the recombinant adeno-associated virus (AAV-shE2F1) knockdown E2F1 gene was injected into the tail vein of 16-weeks-old db/db mice for 8 weeks. The 16-week-old db/db mice were administered metformin (260 mg/kg/d) continuously for 8 weeks. The normal control group (NC) and diabetic model group (DM) were set up simultaneously. Mice renal tubular epithelial cells (mRTECs) were cultured in vitro. The cells were randomly divided into the following groups: normal glucose (NG, containing 5.5 mmol/L glucose), high glucose group (HG, containing 30 mmol/L glucose), NG/HG metformin intervention group (NG/HG + Met), NG/HG negative control siRNA transfection group (NG/HG + Control), NG/HG E2F1 siRNA transfection group (NG/HG + siRNA E2F1), HG metformin intervention and overexpression E2F1 plasmid transfection group (HG + Met + overexpress-E2F1). The expression of related indexes were detected by Western blot, real-time polymerase chain reaction (PCR), immunohistochemistry, and immunofluorescence. The results showed that E2F1 knockdown or metformin reduces the degree of renal fibrosis, DNA damage, and cellular senescence in the DM group; metformin also reduced the expression of E2F1. If E2F1 was overexpressed, the effects of metformin in delaying fibrosis and reducing DNA damage and cellular senescence could be weakened. Thus, metformin alleviates high-glucose-induced senescence and fibrosis of renal tubular epithelial cells by downregulating the expression of E2F1. Frontiers Media S.A. 2022-06-23 /pmc/articles/PMC9262145/ /pubmed/35814218 http://dx.doi.org/10.3389/fphar.2022.926211 Text en Copyright © 2022 Liang, Li, Feng, Yuan, Dai, Wu, Zhang, Wang, Zhou, Liu, Shi, Xiao and Guo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liang, Dan
Li, Zhiyang
Feng, Zhaowei
Yuan, Zhiping
Dai, Yunli
Wu, Xin
Zhang, Fan
Wang, Yuanyuan
Zhou, Yuxia
Liu, Lingling
Shi, Mingjun
Xiao, Ying
Guo, Bing
Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
title Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
title_full Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
title_fullStr Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
title_full_unstemmed Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
title_short Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
title_sort metformin improves the senescence of renal tubular epithelial cells in a high-glucose state through e2f1
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262145/
https://www.ncbi.nlm.nih.gov/pubmed/35814218
http://dx.doi.org/10.3389/fphar.2022.926211
work_keys_str_mv AT liangdan metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT lizhiyang metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT fengzhaowei metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT yuanzhiping metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT daiyunli metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT wuxin metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT zhangfan metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT wangyuanyuan metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT zhouyuxia metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT liulingling metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT shimingjun metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT xiaoying metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1
AT guobing metforminimprovesthesenescenceofrenaltubularepithelialcellsinahighglucosestatethroughe2f1